Three decades of nanopore sequencing, Nat Biotechnol, vol.34, pp.518-542, 2016. ,
Characterization of individual polynucleotide molecules using a membrane channel, Proc Natl Acad Sci, vol.93, pp.13770-13773, 1996. ,
Single-nucleotide discrimination in immobilized DNA oligonucleotides with a biological nanopore, Proc Natl Acad Sci, vol.106, pp.7702-7709, 2009. ,
Processive Replication of Single DNA Molecules in a Nanopore Catalyzed by phi29 DNA Polymerase, J Am Chem Soc, vol.132, pp.17961-72, 2010. ,
Microsecond Time-Scale Discrimination Among Polycytidylic Acid, Polyadenylic Acid, and Polyuridylic Acid as Homopolymers or as Segments Within Single RNA Molecules, Biophys J, vol.77, pp.3227-3260, 1999. ,
Real-time DNA sequencing from single polymerase molecules, Science, vol.323, pp.133-141, 2009. ,
Accurate circular consensus long-read sequencing improves variant detection and assembly of a human genome, Nat Biotechnol, pp.1-8, 2019. ,
Real-time selective sequencing using nanopore technology, Nat Methods, vol.13, pp.751-755, 2016. ,
Haplotype-resolved genome sequencing: experimental methods and applications, Nat Rev Genet, vol.16, pp.344-58, 2015. ,
Mapping DNA methylation with high-throughput nanopore sequencing, Nat Methods, vol.14, pp.411-414, 2017. ,
Detection of DNA base modifications by deep recurrent neural network on Oxford Nanopore sequencing data, Nat Commun, vol.10, p.2449, 2019. ,
Séquençage de l'ADN par nanopores. médecine/sciences, vol.34, pp.161-166, 2018. ,
Overview of Next-Generation Sequencing Technologies, Curr Protoc Mol Biol, vol.122, p.59, 2018. ,
Selective nanopore 88 sequencing of human BRCA1 by Cas9-assisted targeting of chromosome segments (CATCH), Nucleic Acids Res, vol.46, pp.87-87, 2018. ,
Targeted Nanopore Sequencing with Cas9 for studies of methylation, structural variants and mutations. bioRxiv, vol.604173, 2019. ,
Long-read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease, Nat Genet, vol.1, 2019. ,
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity, Science, vol.337, pp.816-837, 2012. ,
Unexpected mutations after CRISPR-Cas9 editing in vivo, Nat Methods, vol.14, pp.547-555, 2017. ,
Correction of a pathogenic gene mutation in human embryos, Nature, vol.548, pp.413-422, 2017. ,
CRISPR/Cas9 ?-globin gene targeting in human haematopoietic stem cells, Nature, vol.539, pp.384-393, 2016. ,
La naissance des « bébés Crispr » suscite une condamnation universelle. Le Monde, 2018. ,
Development and Applications of CRISPR-Cas9 for Genome Engineering, Cell, vol.157, pp.1262-78, 2014. ,
The next generation of CRISPR-Cas technologies and applications, Nat Rev Mol Cell Biol, vol.20, pp.490-507, 2019. ,
Performance of neural network basecalling tools for Oxford Nanopore sequencing, Genome Biol, vol.20, p.129, 2019. ,
Systematic evaluation of error rates and causes in short samples in next-generation sequencing, Sci Rep, vol.8, p.10950, 2018. ,
Illumina error profiles: resolving finescale variation in metagenomic sequencing data, BMC Bioinformatics, vol.17, p.125, 2016. ,
A framework for variation discovery and genotyping using next-generation DNA sequencing data, Nat Genet, vol.43, pp.491-499, 2011. ,
, Association Nationale des Praticiens de Génétique Moléculaire, GT "Cahier des charges informatique, bio-analyse/bioinformatique, bases de données mutations
, Recommandations générales pour la gestion informatique des données et des analyses de séquençage à haut débit pour les laboratoires de diagnostic moléculaire de maladies génétiques
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update, Nucleic Acids Res, vol.46, pp.537-581, 2018. ,
Drug Metabolism and Variability among Patients in Drug Response, N Engl J Med, vol.352, pp.2211-2232, 2005. ,
Personalized pharmacogenomics: predicting efficacy and adverse drug reactions, Annu Rev Genomics Hum Genet, vol.15, pp.349-70, 2014. ,
Genomics and drug response, N Engl J Med, vol.364, pp.1144-53, 2011. ,
Pharmacogenetics or the promise of a personalized medicine: variability in drug metabolism and transport ,
, Ann Biol Clin (Paris), vol.62, pp.499-511, 2004.
Inheritance and Drug Response. Guttmacher AE, Collins FS, N Engl J Med, vol.348, pp.529-566, 2003. ,
Pharmacogenetics -five decades of therapeutic lessons from genetic diversity, Nat Rev Genet, vol.5, pp.669-76, 2004. ,
Omics and drug response, Annu Rev Pharmacol Toxicol, vol.53, pp.475-502, 2013. ,
, Pharmacogenomics. Lancet, vol.394, pp.521-553, 2019.
Development of the PG x-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing, Clin Pharmacol Ther, 2019. ,
Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response, Genet Med, vol.19, pp.20-29, 2017. ,
The global spectrum of protein-coding pharmacogenomic diversity, Pharmacogenomics J, vol.18, pp.187-95, 2018. ,
Nomenclature for human CYP2D6 alleles, Pharmacogenetics, vol.6, pp.193-201, 1996. ,
Ten Years' Experience with the CYP2D6 Activity Score: A Perspective on Future Investigations to Improve Clinical Predictions for Precision Therapeutics, J Pers Med, vol.8, p.15, 2018. ,
Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity, Pharmacogenomics J, vol.5, pp.6-13, 2005. ,
Interethnic variability of CYP2D6 alleles and of predicted and measured metabolic phenotypes across world populations, Expert Opin Drug Metab Toxicol, vol.10, pp.1569-83, 2014. ,
The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype, Clin Pharmacol Ther, vol.83, pp.234-276, 2008. ,
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation, Pharmacol Ther, vol.138, pp.103-144, 2013. ,
Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study, The Lancet Psychiatry, vol.6, pp.418-444, 2019. ,
Genome-wide association study identifies the common variants in CYP3A4 and CYP3A5 responsible for variation in tacrolimus trough concentration in Caucasian kidney transplant recipients, Pharmacogenomics J, vol.18, pp.501-506, 2018. ,
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing, Clin Pharmacol Ther, vol.98, pp.19-24, 2015. ,
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT 15 Genotypes, Clin Pharmacol Ther, vol.105, pp.1095-105, 2018. ,
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity, Nat Genet, vol.48, pp.367-73, 2016. ,
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease, JAMA, vol.321, p.773, 2019. ,
Nonsynonymous Polymorphism in Guanine Monophosphate Synthetase Is a Risk Factor for Unfavorable Thiopurine Metabolite Ratios in Patients With Inflammatory Bowel Disease, Inflamm Bowel Dis, vol.24, pp.2606-2618, 2018. ,
HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease, Aliment Pharmacol Ther, vol.47, pp.615-635, 2018. ,
HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants, Nat Genet, vol.46, pp.1131-1135, 2014. ,
Diagnostic and Therapeutic Strategies for Fluoropyrimidine Treatment of Patients Carrying Multiple DPYD Variants, Genes (Basel), vol.9, p.585, 2018. ,
Explaining TPMT genotype/phenotype discrepancy by haplotyping of TPMT*3A and identification of a novel sequence variant, TPMT*23, Pharmacogenet Genomics, vol.17, pp.891-896, 2007. ,
, Recherche de déficit en dihydropyrimidine déshydrogénase en vue de prévenir certaines toxicités sévères survenant sous traitement comportant des fluoropyrimidines (5-fluorouracile), Recommandations et référentiels, INCa, HAS. Décembre, 2018.
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis, Lancet Oncol, vol.19, pp.1459-67, 2018. ,
Dihydropyrimidine déhydrogenase (DPD) deficiency screening and securing of fluoropyrimidine-based chemotherapies: Update and recommendations of the French GPCO-Unicancer and ,
, Bull Cancer, vol.105, pp.397-407, 2018.
DPYD genotype-guided dose individualization to improve patient safety of fluoropyrimidine therapy: call for a drug label update, Ann Oncol, vol.28, pp.2915-2937, 2017. ,
, A global reference for human genetic variation, Nature, vol.526, pp.68-74, 2015.
, Bull Cancer, vol.101, pp.533-53, 2014.
Pharmacogenetics of immunosuppressants: State of the art and clinical implementation -recommendations from the French National Network of Pharmacogenetics (RNPGx), Therapies, vol.72, pp.285-99, 2017. ,
Advancements in Next-Generation Sequencing, Annu Rev Genomics Hum Genet, vol.17, pp.95-115, 2016. ,
The next-generation sequencing revolution and its impact on genomics, Cell, vol.155, pp.27-38, 2013. ,
Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries, Genome Biol, vol.12, p.18, 2011. ,
Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments, AAPS J, vol.20, p.4, 2018. ,
Nanopore metagenomics enables rapid clinical diagnosis of bacterial lower respiratory infection, Nat Biotechnol, vol.37, pp.783-792, 2019. ,
Real-time, portable genome sequencing for Ebola surveillance, Nature, vol.530, pp.228-260, 2016. ,
Chromosome-scale assemblies of plant genomes using nanopore long reads and optical maps, Nat Plants, vol.4, pp.879-87, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01977046
Sequencing of human genomes with nanopore technology, Nat Commun, vol.10, p.1869, 2019. ,
Nanopore sequencing and assembly of a human genome with ultra-long reads, Nat Biotechnol, vol.36, pp.338-383, 2018. ,
Nanopore sequencing of the pharmacogene CYP2D6 allows simultaneous haplotyping and detection of duplications. bioRxiv, vol.576280, 2019. ,
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia, Sci Rep, vol.8, p.11798, 2018. ,
A Simple Thermoplastic Substrate Containing Hierarchical Silica Lamellae for High-MolecularWeight DNA Extraction, Adv Mater, vol.28, pp.10630-10636, 2016. ,
CHOPCHOP v2: a web tool for the next generation of CRISPR genome engineering, Nucleic Acids Res, vol.44, pp.272-278, 2016. ,
Minimap2: pairwise alignment for nucleotide sequences. Birol I, editor, Bioinformatics, vol.34, pp.3094-100, 2018. ,
A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data, Bioinformatics, vol.27, pp.2987-93, 2011. ,
Haplotype-based variant detection from short-read sequencing, 2012. ,
Detecting DNA cytosine methylation using nanopore sequencing, Nat Methods, vol.14, pp.407-417, 2017. ,
WhatsHap: fast and accurate read-based phasing, bioRxiv, vol.085050, 2016. ,
Bioconda: sustainable and comprehensive software distribution for the life sciences, Nat Methods, vol.15, pp.475-481, 2018. ,
Integrative genomics viewer, Nat Biotechnol, vol.29, pp.24-30, 2011. ,
NanoPack: visualizing and processing long-read sequencing data, Bioinformatics, vol.34, pp.2666-2675, 2018. ,
Snakemake--a scalable bioinformatics workflow engine, Bioinformatics, vol.28, pp.2520-2522, 2012. ,
Fast and accurate short read alignment with Burrows-Wheeler transform, Bioinformatics, vol.25, pp.1754-60, 2009. ,
VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing, Genome Res, vol.22, pp.568-76, 2012. ,
A universal SNP and small-indel variant caller using deep neural networks, Nat Biotechnol, vol.36, pp.983-990, 2018. ,
The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data, Genome Res, vol.20, pp.1297-303, 2010. ,
SpeedSeq: ultra-fast personal genome analysis and interpretation, Nat Methods, vol.12, pp.966-974, 2015. ,
Comparison of three variant callers for human whole genome sequencing, Sci Rep, vol.8, p.17851, 2018. ,
A multi-task convolutional deep neural network for variant calling in single molecule sequencing, Nat Commun, vol.10, p.998, 2019. ,
Performance assessment of variant calling pipelines using human whole exome sequencing and simulated data, BMC Bioinformatics, vol.20, p.342, 2019. ,
Comparison of single-nucleotide variants identified by Illumina and Oxford Nanopore technologies in the context of a potential outbreak of Shiga toxin-producing Escherichia coli, Gigascience, vol.8, 2019. ,
A Multiplex Pharmacogenetics Assay using the MinION Nanopore Sequencing Device ,
, , vol.563262
A novel CRISPR/Cas9 associated technology for sequence-specific nucleic acid enrichment, PLoS One, vol.14, p.215441, 2019. ,
Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinION, Mol Genet Genomic Med, vol.7, p.564, 2019. ,
Using dried blood spot samples from a trio for linked-read whole-exome sequencing, Eur J Hum Genet, vol.27, pp.980-988, 2019. ,
Haplotyping germline and cancer genomes with high-throughput linked-read sequencing, Nat Biotechnol, vol.34, pp.303-314, 2016. ,
Epigenomics and Interindividual Differences in Drug Response, Clin Pharmacol Ther, vol.92, pp.727-763, 2012. ,
Population genetic inference from genomic sequence variation, Genome Res, vol.20, pp.291-300, 2010. ,
Analysis of population-specific pharmacogenomic variants using nextgeneration sequencing data, Sci Rep, vol.7, p.8416, 2017. ,
Systematic comparison of variant calling pipelines using gold standard personal exome variants, Sci Rep, vol.5, p.17875, 2015. ,
Increasing the accuracy of nanopore DNA sequencing using a time-varying cross membrane voltage, Nat Biotechnol, vol.37, pp.651-657, 2019. ,
From squiggle to basepair: computational approaches for improving nanopore sequencing read accuracy, Genome Biol, vol.19, p.90, 2018. ,